Pular para o conteúdo principal

ETHNOS_APP

Início • Busca • Periódicos • Lista 0

Albino J Oliveira-Maia

Dados Biográficos

ID1912405
NOMEAlbino J Oliveira-Maia
PRENOMESAlbino J
SOBRENOMEOliveira-Maia
ASSINATURAOLIVEIRA-MAIA A J
AFILIAÇÕESChampalimaud Foundation
ORCID0000-0001-5071-3007
VERIFICADOSim
TOTAL DE OBRAS11
TOTAL DE CITAÇÕES0
TOTAL COMO AUTOR11
TOTAL COMO EDITOR0
PRIMEIRO ANO DE PUBLICAÇÃO2018
ANO MAIS RECENTE DE PUBLICAÇÃO2025
ÍNDICE H0
  • Changes over time in self-efficacy to cope with cancer and well-being in women with breast cancer

    Evangelos C Karademas, Ilan Roziner et al.•ARTICLE•Psychology & Health•2025

    OBJECTIVE: This study aimed to examine whether self-efficacy to cope with cancer changes over time in patients with breast cancer and whether these potential changes are similar across patients. It also aimed to examine whether these trajectories are related to patient psychological well-being and overall quality of life. METHODS: = 404) from four countries (i.e. Finland, Israel, Italy, and Portugal) were enrolled in the study few weeks after bre…

  • Estimating the benefit of esketamine nasal spray versus real-world treatment on patient-reported functional remission

    Open Access•Albino J Oliveira-Maia, Benoît Rive et al.•ARTICLE•Frontiers in Psychiatry•2024

    For patients with TRD, esketamine NS had a significant functional benefit versus RWT after 6 months of treatment. Irrespective of treatment, achievement of clinical response or remission was insufficient to attain functional remission. Nevertheless, clinical remission increased the likelihood of achieving functional remission, further supporting an important role for clinical remission in for the path towards functional recovery

  • Reducing motor evoked potential amplitude variability through normalization

    Open Access•Francisco Faro Viana, Gonçalo Cotovio et al.•ARTICLE•Frontiers in Psychiatry•2024

    Background Transcranial Magnetic Stimulation (TMS) is used for in vivo assessment of human motor cortical excitability, with application of TMS pulses over the motor cortex resulting in muscle responses that can be recorded with electromyography (EMG) as Motor Evoked Potentials (MEPs). These have been widely explored as potential biomarkers for neuropsychiatric disorders but methodological heterogeneity in acquisition, and inherent high variabili…

  • The mutual determination of self-efficacy to cope with cancer and cancer-related coping over time

    Evangelos C Karademas, Ilan Roziner et al.•ARTICLE•Psychology & Health•2023

    OBJECTIVE: The aim of this study was to examine the longitudinal impact of self-efficacy to cope with cancer on the cancer-related coping reactions of breast cancer patients and vice versa. DESIGN AND MAIN OUTCOMES MEASURES: = 403) were enrolled in the study a few weeks after surgery or biopsy. Coping self-efficacy was assessed at baseline and six months later (M6). Cancer-related coping was assessed three (M3) and nine months (M9) after baseline…

  • Iceberg study

    Open Access•Albino J Oliveira-Maia, Joachim Morrens et al.•ARTICLE•Frontiers in Psychiatry•2023

    ICEBERG supports that, at 6 months, esketamine NS has a substantial and significant benefit over RWT for patients with TRD. While results may be affected by unobserved confounding factors, threshold analyses suggested these were unlikely to impact the study conclusions.To view an animated summary of this publication, please click on the Supplementary video

  • Treatment-Resistant Depression in Portugal

    Open Access•João M Bessa, Serafim Carvalho et al.•ARTICLE•Frontiers in Psychiatry•2022

    Guidance about treatment-resistant depression (TRD) in Portugal is very limited, even though depression prevalence is among the highest in European countries. A questionnaire was conducted, followed by two advisory boards with seven Portuguese psychiatry experts, to characterize and discuss MDD and TRD epidemiology, diagnosis, patient journey, treatment options, and unmet clinical needs. Consensus was reached on the main issues. In daily practice…

  • Symptom provocation for treatment of obsessive-compulsive disorder using transcranial magnetic stimulation

    Open Access•Ana Maia, Sílvia Almeida et al.•ARTICLE•Frontiers in Psychiatry•2022

    Transcranial Magnetic Stimulation (TMS) is a non-invasive brain stimulation technique that was cleared by the Food and Drug Administration (FDA) for the treatment of Obsessive-Compulsive Disorder (OCD) in 2018. The approved protocol includes individualized symptom provocation before each stimulation session, to elicit a moderate level of obsessional distress. Although symptom provocation can be a delicate, demanding, and uncomfortable procedure, …

  • Explicit knowledge of task structure is a primary determinant of human model-based action

    Open Access•Pedro Castro-Rodrigues, Thomas Akam et al.•ARTICLE•Nature Human Behaviour•2022•Referências: 69

  • Protocol for the Implementation and Assessment of “MoodUP”

    Open Access•Diana Frasquilho, Ricardo Matias et al.•ARTICLE•International Journal of…•2021

    The COVID-19 pandemic has important consequences for the mental health of populations. Patients with cancer, already at risk for poor mental health outcomes, are not expected to be spared from these consequences, prompting the need for health services to improve responsiveness. This article presents the research protocol for an implementation study designed to describe the uptake of a well-studied and recognized system for the treatment of depres…

  • Hypomania Symptoms Across Psychiatric Disorders

    Open Access•Marta Camacho, Sílvia Almeida et al.•ARTICLE•Frontiers in Psychiatry•2018

    Introduction: Hypomania symptoms are best described as a continuum, ranging beyond Bipolar Spectrum Disorders (BSD). Other nosological entities, such as major depressive disorder, schizoaffective disorder, or borderline personality disorder, may also share symptoms with BSD, raising challenges for differential diagnosis. While the Hypomania Checklist-32 is one of the most widely used tools for screening hypomania, there is limited evidence descri…

  • Criterion Validity of the Yale-Brown Obsessive-Compulsive Scale Second Edition for Diagnosis of Obsessive-Compulsive Disorder in Adults

    Open Access•Pedro Castro-Rodrigues, Marta Camacho et al.•ARTICLE•Frontiers in Psychiatry•2018

    Background: While the Yale-Brown Obsessive-Compulsive Scale Second Edition (Y-BOCS-II) is the gold-standard for measurement of obsessive-compulsive (OC) symptom severity, its factor structure is still a matter of debate and, most importantly, criterion validity for diagnosis of OC disorder (OCD) has not been tested. This study aimed to clarify factor structure and criterion validity of the Y-BOCS-II. Methods: We first validated and quantified the…

Sem obras proeminentes nesta página.

  • Hypomania Symptoms Across Psychiatric Disorders

    Open Access•Marta Camacho, Sílvia Almeida et al.•ARTICLE•Frontiers in Psychiatry•2018

    Introduction: Hypomania symptoms are best described as a continuum, ranging beyond Bipolar Spectrum Disorders (BSD). Other nosological entities, such as major depressive disorder, schizoaffective disorder, or borderline personality disorder, may also share symptoms with BSD, raising challenges for differential diagnosis. While the Hypomania Checklist-32 is one of the most widely used tools for screening hypomania, there is limited evidence descri…

  • Criterion Validity of the Yale-Brown Obsessive-Compulsive Scale Second Edition for Diagnosis of Obsessive-Compulsive Disorder in Adults

    Open Access•Pedro Castro-Rodrigues, Marta Camacho et al.•ARTICLE•Frontiers in Psychiatry•2018

    Background: While the Yale-Brown Obsessive-Compulsive Scale Second Edition (Y-BOCS-II) is the gold-standard for measurement of obsessive-compulsive (OC) symptom severity, its factor structure is still a matter of debate and, most importantly, criterion validity for diagnosis of OC disorder (OCD) has not been tested. This study aimed to clarify factor structure and criterion validity of the Y-BOCS-II. Methods: We first validated and quantified the…

  • Protocol for the Implementation and Assessment of “MoodUP”

    Open Access•Diana Frasquilho, Ricardo Matias et al.•ARTICLE•International Journal of…•2021

    The COVID-19 pandemic has important consequences for the mental health of populations. Patients with cancer, already at risk for poor mental health outcomes, are not expected to be spared from these consequences, prompting the need for health services to improve responsiveness. This article presents the research protocol for an implementation study designed to describe the uptake of a well-studied and recognized system for the treatment of depres…

  • Treatment-Resistant Depression in Portugal

    Open Access•João M Bessa, Serafim Carvalho et al.•ARTICLE•Frontiers in Psychiatry•2022

    Guidance about treatment-resistant depression (TRD) in Portugal is very limited, even though depression prevalence is among the highest in European countries. A questionnaire was conducted, followed by two advisory boards with seven Portuguese psychiatry experts, to characterize and discuss MDD and TRD epidemiology, diagnosis, patient journey, treatment options, and unmet clinical needs. Consensus was reached on the main issues. In daily practice…

  • Symptom provocation for treatment of obsessive-compulsive disorder using transcranial magnetic stimulation

    Open Access•Ana Maia, Sílvia Almeida et al.•ARTICLE•Frontiers in Psychiatry•2022

    Transcranial Magnetic Stimulation (TMS) is a non-invasive brain stimulation technique that was cleared by the Food and Drug Administration (FDA) for the treatment of Obsessive-Compulsive Disorder (OCD) in 2018. The approved protocol includes individualized symptom provocation before each stimulation session, to elicit a moderate level of obsessional distress. Although symptom provocation can be a delicate, demanding, and uncomfortable procedure, …

  • Explicit knowledge of task structure is a primary determinant of human model-based action

    Open Access•Pedro Castro-Rodrigues, Thomas Akam et al.•ARTICLE•Nature Human Behaviour•2022•Referências: 69

  • The mutual determination of self-efficacy to cope with cancer and cancer-related coping over time

    Evangelos C Karademas, Ilan Roziner et al.•ARTICLE•Psychology & Health•2023

    OBJECTIVE: The aim of this study was to examine the longitudinal impact of self-efficacy to cope with cancer on the cancer-related coping reactions of breast cancer patients and vice versa. DESIGN AND MAIN OUTCOMES MEASURES: = 403) were enrolled in the study a few weeks after surgery or biopsy. Coping self-efficacy was assessed at baseline and six months later (M6). Cancer-related coping was assessed three (M3) and nine months (M9) after baseline…

  • Iceberg study

    Open Access•Albino J Oliveira-Maia, Joachim Morrens et al.•ARTICLE•Frontiers in Psychiatry•2023

    ICEBERG supports that, at 6 months, esketamine NS has a substantial and significant benefit over RWT for patients with TRD. While results may be affected by unobserved confounding factors, threshold analyses suggested these were unlikely to impact the study conclusions.To view an animated summary of this publication, please click on the Supplementary video

  • Estimating the benefit of esketamine nasal spray versus real-world treatment on patient-reported functional remission

    Open Access•Albino J Oliveira-Maia, Benoît Rive et al.•ARTICLE•Frontiers in Psychiatry•2024

    For patients with TRD, esketamine NS had a significant functional benefit versus RWT after 6 months of treatment. Irrespective of treatment, achievement of clinical response or remission was insufficient to attain functional remission. Nevertheless, clinical remission increased the likelihood of achieving functional remission, further supporting an important role for clinical remission in for the path towards functional recovery

  • Reducing motor evoked potential amplitude variability through normalization

    Open Access•Francisco Faro Viana, Gonçalo Cotovio et al.•ARTICLE•Frontiers in Psychiatry•2024

    Background Transcranial Magnetic Stimulation (TMS) is used for in vivo assessment of human motor cortical excitability, with application of TMS pulses over the motor cortex resulting in muscle responses that can be recorded with electromyography (EMG) as Motor Evoked Potentials (MEPs). These have been widely explored as potential biomarkers for neuropsychiatric disorders but methodological heterogeneity in acquisition, and inherent high variabili…

  • Changes over time in self-efficacy to cope with cancer and well-being in women with breast cancer

    Evangelos C Karademas, Ilan Roziner et al.•ARTICLE•Psychology & Health•2025

    OBJECTIVE: This study aimed to examine whether self-efficacy to cope with cancer changes over time in patients with breast cancer and whether these potential changes are similar across patients. It also aimed to examine whether these trajectories are related to patient psychological well-being and overall quality of life. METHODS: = 404) from four countries (i.e. Finland, Israel, Italy, and Portugal) were enrolled in the study few weeks after bre…

Medicine (10 obras) · Psychology (7 obras) · Clinical Psychology (5 obras) · Internal Medicine (5 obras) · Psychiatry (5 obras) · Anxiety (3 obras) · Cancer survivorship and care (3 obras) · Clinical Psychology (3 obras) · Depression (economics (3 obras) · Major depressive disorder (3 obras)

Ethnos_APP • Projeto Open Source • Licença MIT • Frontend v2.0.0 • Privacidade e Cookies • Documentação da API: api.ethnos.app/docs • Código da API: GitHub • DOI: 10.5281/zenodo.17049435 • Código do Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae